| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
8,320,000 |
| Market
Cap: |
4.33(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.34 - $4.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Yumanity Therapeutics is a biopharmaceutical company focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. Co.'s primary program, YTX-7739, is in development for the potential treatment and disease modification of Parkinson's disease. YTX-7739 targets an enzyme known as stearoyl-CoA desaturase (SCD). Inhibition of SCD in multiple cellular systems, including patient-derived neurons, as well as in a mouse model of Parkinson's disease, has been demonstrated to reverse the toxicity of misfolded alpha-synuclein, a protein strongly associated with Parkinson's disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
10,250 |
50,250 |
57,251 |
| Total Buy Value |
$0 |
$37,160 |
$130,875 |
$174,456 |
| Total People Bought |
0 |
3 |
6 |
6 |
| Total Buy Transactions |
0 |
6 |
16 |
18 |
| Total Shares Sold |
0 |
0 |
0 |
47,617 |
| Total Sell Value |
$0 |
$0 |
$0 |
$88,083 |
| Total People Sold |
0 |
0 |
0 |
7 |
| Total Sell Transactions |
0 |
0 |
0 |
15 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fmr Corp |
See Remark 1 |
– – • |
2017-03-03 |
4 |
S |
$13.63 |
$272,600 |
I/I |
(20,000) |
382,808 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2017-03-02 |
4 |
S |
$14.03 |
$353,225 |
I/I |
(25,000) |
402,808 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2017-02-27 |
4 |
S |
$14.65 |
$219,750 |
I/I |
(15,000) |
472,808 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2017-02-24 |
4 |
S |
$14.55 |
$189,150 |
I/I |
(13,000) |
487,808 |
|
- |
|
| Fmr Corp |
10% Owner |
– – • |
2017-02-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
500,808 |
|
- |
|
| Berger Franklin M |
Director |
– • – |
2016-12-16 |
4 |
B |
$11.52 |
$161,342 |
D/D |
14,000 |
206,162 |
2.39 |
- |
|
| Berger Franklin M |
Director |
– • – |
2016-12-15 |
4 |
B |
$10.99 |
$285,626 |
D/D |
26,000 |
192,162 |
2.39 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-13 |
4 |
B |
$10.98 |
$233,955 |
I/I |
21,301 |
3,804,027 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-12 |
4 |
B |
$10.79 |
$1,078,950 |
I/I |
100,000 |
3,782,726 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-08 |
4 |
B |
$10.93 |
$238,482 |
I/I |
21,819 |
3,682,726 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-07 |
4 |
B |
$10.74 |
$242,707 |
I/I |
22,598 |
3,660,907 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-06 |
4 |
B |
$10.89 |
$89,441 |
I/I |
8,216 |
3,638,309 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-05 |
4 |
B |
$10.78 |
$320,882 |
I/I |
29,757 |
3,630,093 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-02 |
4 |
B |
$10.48 |
$523,800 |
I/I |
50,000 |
3,600,336 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-12-01 |
4 |
B |
$10.11 |
$424,593 |
I/I |
41,984 |
3,550,336 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-29 |
4 |
B |
$10.28 |
$1,319,523 |
I/I |
128,407 |
3,508,352 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-23 |
4 |
B |
$10.67 |
$2,052,506 |
I/I |
180,500 |
3,379,945 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-22 |
4 |
B |
$11.08 |
$769,817 |
I/I |
69,500 |
3,199,445 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-21 |
4 |
B |
$11.64 |
$1,302,622 |
I/I |
111,863 |
3,129,945 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-14 |
4 |
B |
$11.48 |
$109,016 |
I/I |
9,500 |
3,018,082 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-11 |
4 |
B |
$11.46 |
$242,975 |
I/I |
21,200 |
3,008,582 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-10 |
4 |
B |
$11.07 |
$2,398,587 |
I/I |
216,700 |
2,987,382 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-09 |
4 |
B |
$9.68 |
$117,121 |
I/I |
12,100 |
2,770,682 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-07 |
4 |
B |
$8.69 |
$2,012,616 |
I/I |
231,700 |
2,758,582 |
1.5 |
- |
|
| Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
– – • |
2016-11-04 |
4 |
B |
$7.27 |
$612,901 |
I/I |
76,000 |
2,526,882 |
1.5 |
- |
|
147 Records found
|
|
Page 5 of 6 |
|
|
